Question 1

What is the catalog number for Human SH3D19 Knockout A549 cell line?

Accepted Answer

The catalog number for Human SH3D19 Knockout A549 cell line is A549KO-18268.

Question 2

What sizes are available for Human SH3D19 Knockout A549 cell line?

Accepted Answer

Human SH3D19 Knockout A549 cell line is available in the following size(s): 1 Vial.

Question 3

Is Human SH3D19 Knockout A549 cell line in stock?

Accepted Answer

Human SH3D19 Knockout A549 cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Human SH3D19 Knockout A549 cell line used for?

Accepted Answer

Engineered clonal A549 cells with SH3D19 gene knockout, sequence confirmed.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 7

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Human SH3D19 Knockout A549 cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

Tissue FFPE Sections, Breast

[1,1′:4′,1′′:4′′,1′′′-Quaterphenyl]-4-thiol.

P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/11), 0.2mg/mL

MM 2-10 [N- (3-Triethylammoniumpropyl) -4- (4- (diethylamino) styryl) pyridinium dibromide]

Mouse IL-3 Recombinant Rabbit monoclonal Antibody

MelanA (MLANA) Mouse Monoclonal Antibody [Clone ID: A103 + M2-7C10 + M2-9E3]